Yair Lotan

44PUBLICATIONS
206CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Jul 28, 2026
Unveiling the Paradoxical Tumor-Suppressive Role of CCL2/CCR2 in Bladder Cancer: A Novel Immunotherapeutic Strategy.

|Jul 02, 2026
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

|Apr 28, 2026
'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Mar 27, 2026
Novel Immune Checkpoint Inhibitor and Antibody-Drug Conjugate Approaches in the Perioperative Management of Muscle-Invasive Bladder Cancer.

Joseph Vento, Tian Zhang, Yair Lotan

Pageof 8

Frequent Collaborators

7 joint publications

Roger Li

5 joint publications

Laura S Mertens

4 joint publications

Andrea Mari

4 joint publications

Siamak Daneshmand